Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A trial found adding low-dose megestrol to anti-estrogen therapy slowed tumor growth in post-menopausal women with ER-positive breast cancer.
A Cambridge-led trial found that adding low-dose megestrol acetate, a synthetic progesterone, to anti-estrogen therapy slowed tumor growth in post-menopausal women with ER-positive breast cancer.
In the PIONEER study, 198 patients receiving the combination treatment showed greater reductions in tumor growth than those on anti-estrogen therapy alone.
The drug, already used to manage treatment side effects like hot flashes, may improve adherence and outcomes.
While further research is needed, the results suggest megestrol could offer both symptom relief and direct anti-cancer benefits.
3 Articles
Un ensayo encontró que la adición de dosis bajas de megestrol a la terapia antiestrogénica ralentizó el crecimiento tumoral en mujeres posmenopáusicas con cáncer de mama ER positivo.